Latest news
NYSE Content Update: Expedition Therapeutics Secures $115 Millio - GuruFocusGuruFocus · Wed, 05 Aug 2026 15:05:23 GMTRatio Therapeutics raises $70m to expand radiopharmaceutical manufacturing - Manufacturing ChemistManufacturing Chemist · Mon, 03 Aug 2026 11:58:46 GMTRatio Therapeutics secures $70m Series C funding for cancer radiotherapy - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 09:45:58 GMTNovartis secures expanded approval for Pluvicto - AuntMinnieAuntMinnie · Sat, 01 Aug 2026 03:06:40 GMTRatio Therapeutics Secures $70 Million Series C Financing To Advance Clinical Development Of Targeted Radiotherapeutics Pipeline - Pulse 2.0Pulse 2.0 · Fri, 31 Jul 2026 19:19:14 GMTRatio Therapeutics adds to coffers - AuntMinnieAuntMinnie · Fri, 31 Jul 2026 17:06:38 GMTRatio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure - PR NewswirePR Newswire · Fri, 31 Jul 2026 07:00:00 GMTAlterity Therapeutics (NASDAQ: ATHE) outlines FDA-backed Phase 3 plan for ATH434 - Stock TitanStock Titan · Thu, 30 Jul 2026 10:05:21 GMT